ArticleClinics (Sao Paulo, Brazil)2026
The economic impact of COVID-19: a comparative cost analysis of ICU hospitalizations before and during the pandemic.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 economic impact on health institutions has been discussed since the beginning of the pandemic, and the repercussions in different spheres were enormous. The economic evaluation in health became necessary as a management tool.
objectiveTo describe and compare the hospitalization costs in Intensive Care Units (ICUs) and the patients' clinical and demographic variables, before and during the COVID-19 pandemic. DATA SOURCES AND STUDY
settingPartial economic evaluation of patients admitted to four ICUs, in a Brazilian reference center, in two periods: pre-pandemic (03/30/19 ‒ 06/30/19) and pandemic (03/30/20 ‒ 06/30/20). STUDY
designObservational cohort study. DATA COLLECTION/EXTRACTION
methodsMicro and macro costing methodology; clinical and demographic variables were considered for the comparative analysis.
resultsIn 2019, 521 hospitalizations were analyzed. Patients were predominantly male (61%), between 31- and 60-years old (48.2%) and of white race (75.4%). In 2020, 610 hospitalizations were analyzed: 60.3% male, 51.6% > 60-years old and 65.2% white race. All ICUs had an increase in deaths (2019: average of 26.9%; 2020: average of 48.8%). The average total hospitalization costs and the average patient-day cost in 2019 was US$ 6051.01 and US$ 787.48, respectively; in 2020, US$ 19,492.73 and US$ 1542.74. Human resources was the component with the highest cost (2019: 51.6%; 2020: 78.2%). Patients who require additional therapeutic procedures had a higher average cost in 2020.
conclusionDuring COVID, patients were older (> 60-years), a higher percentage of patients identified as mixed race, the death rate was significantly higher, and the length of stay was significantly higher, resulting in the outcome "discharge". The COVID cost was significantly higher. The main cost component was human resources, mainly during the COVID pandemic. Additional therapeutic procedures were associated with higher costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.